DIVERSIMAB Trademark

Trademark Overview


On Tuesday, July 13, 2021, a trademark application was filed for DIVERSIMAB with the United States Patent and Trademark Office. The USPTO has given the DIVERSIMAB trademark a serial number of 90825952. The federal status of this trademark filing is REGISTERED as of Tuesday, October 4, 2022. This trademark is owned by AbX Biologics, Inc.. The DIVERSIMAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research services for others in the field of genetics and monoclonal antibodies; Research and development services in the field of monoclonal antibodies, namely, development of antibody-based therapeutics and discovery of reagents; Research and development services in the field of monoclonal antibodies, namely, generation of therapeutic and reagent antibodies; Genetic engineering services, namely, the production of genetically-engineered mice and monoclonal antibodies for others
diversimab

General Information


Serial Number90825952
Word MarkDIVERSIMAB
Filing DateTuesday, July 13, 2021
Status700 - REGISTERED
Status DateTuesday, October 4, 2022
Registration Number6862661
Registration DateTuesday, October 4, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements


Pseudo MarkDIVERS IM A B
Goods and ServicesScientific research services for others in the field of genetics and monoclonal antibodies; Research and development services in the field of monoclonal antibodies, namely, development of antibody-based therapeutics and discovery of reagents; Research and development services in the field of monoclonal antibodies, namely, generation of therapeutic and reagent antibodies; Genetic engineering services, namely, the production of genetically-engineered mice and monoclonal antibodies for others

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 17, 2022
Primary Code042
First Use Anywhere DateSaturday, November 1, 2014
First Use In Commerce DateSaturday, November 1, 2014

Trademark Owner History


Party NameAbX Biologics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCanton, MA 02021

Party NameAbX Biologics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCanton, MA 02021

Party NameAbX Biologics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCanton, MA 02021

Trademark Events


Event DateEvent Description
Tuesday, October 4, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 4, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 14, 2022NON-FINAL ACTION E-MAILED
Tuesday, June 14, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, April 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, April 24, 2022NON-FINAL ACTION E-MAILED
Sunday, April 24, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 30, 2022ASSIGNED TO EXAMINER
Friday, September 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 16, 2021NEW APPLICATION ENTERED